All Members

It is with profound sadness that we announce the passing of Dr. Albert Starr, a pioneer in the field of cardiothoracic surgery, who passed away on Dec. 12, 2024, at age 98. Dr. Starr served as the 21st president of The Society of Thoracic Surgeons from 1985 to 1986, leaving an enduring impact on the specialty and the Society.

Image

Dr. Starr received his medical degree from Columbia University College of Physicians and Surgeons in 1954. After an internship at Johns Hopkins, he completed his general and thoracic surgical residencies at Bellevue and Presbyterian Hospitals in New York City. He was recruited to Oregon in 1957 to head a new heart surgery program at the University of Oregon Medical School, now the Oregon Health & Science University Heart Institute.

His drive for innovation led him to collaborate with engineer Lowell Edwards, which resulted in the development of the Starr-Edwards heart valve—one of the first successful artificial heart valves used in humans. The Starr-Edwards valve revolutionized the treatment of valvular heart disease and is considered one of the most significant advances in cardiac surgery in the 20th century.

Throughout his career, Dr. Starr remained a tireless advocate for the improvement of heart valve surgery. His pioneering work not only advanced surgical techniques but also laid the groundwork for the development of future generations of heart valves. His leadership in cardiothoracic surgery, both in the operating room and in the broader medical community, earned him recognition as a visionary in the field.

Dr. Starr’s tenure as president of The Society of Thoracic Surgeons was marked by his passion for fostering education, research, and collaboration within the Society. He was instrumental in advancing the Society’s mission of improving patient care through the dissemination of knowledge and the promotion of cutting-edge surgical practices.

“The positive forces of technological innovation, entrepreneurial activity, and capital availability will ensure a future of opportunity and growth,” Dr. Starr said in his 1986 presidential address. “The thoracic surgical industry will continue to be a source of great excitement to us and of benefit to our patients.”

Dr. Starr was the 2007 co-recipient of the prestigious Albert Lasker Award for Clinical Medical Research with Alain Carpentier in recognition of their development of prosthetic mitral and aortic valves, which have prolonged and enhanced the lives of millions of people with heart disease.

Beyond his clinical and academic contributions, Dr. Starr was a beloved mentor, guiding countless residents, international fellows and surgeons who would go on to achieve their own successes. His kindness, wisdom, and dedication to improving patient outcomes will continue to inspire those in the field for generations to come.

His legacy in the field of thoracic surgery is immeasurable, and his memory will continue to shape the future of our profession.

Learn more about Dr. Starr here and here.

David A. Fullerton, MD, Renowned Cardiothoracic Surgeon and Former President of The Society of Thoracic Surgeons, Dies at 72

Dr. David Fullerton, the ultimate gentleman surgeon, trainee advocate, and protector of patient safety, passed away peacefully on Dec. 15, 2024, at the age of 72. His death marks the loss of a revered physician, educator, and leader whose contributions to the specialty have left an indelible mark on the lives of countless patients and medical professionals alike.

Image

Over the course of his distinguished career, he became known for his exceptional skill in complex procedures, his compassionate care, and his tireless commitment to advancing the practice of cardiothoracic surgery and critical care.

Born in Texas, Dr. Fullerton received his undergraduate degree from Southern Methodist University and his medical degree from the University of Missouri School of Medicine. He completed a residency in general surgery at the University of Washington and a cardiothoracic surgery residency at the University of Colorado.

Dr. Fullerton went on to work at Northwestern University in Chicago as Chief of Cardiothoracic Surgery and Director of the Thoracic Surgery Residency Program. He later returned to the University of Colorado, where he led the Division of Cardiothoracic Surgery from 2003-2022, while also serving as Director of Cardiothoracic Surgical Research and Director of the University’s Thoracic Surgery Residency Program. In addition, he served as Cardiac Surgeon-in-Chief and Co-Medical Director of the Cardiothoracic Surgical Intensive Care Unit for the University of Colorado Hospital.

A leader within the medical community, Dr. Fullerton served as president of The Society of Thoracic Surgeons in 2014-15. Under his leadership, STS made significant strides in enhancing surgical standards, promoting innovation, and fostering collaboration among clinicians and researchers. His advocacy for improved quality metrics and the incorporation of evidence-based practices in thoracic surgery earned him respect among his peers and inspired the next generation of surgeons. In his presidential address, Dr. Fullerton made an impassioned plea for expanding access to heart and lung surgery in underserved areas of the world.

Dr. Fullerton also dedicated a significant part of his professional career to the American Board of Thoracic Surgeons, serving as a Director, then as Chairman and Executive Director. Reflecting on his time with the ABTS, Dr. Fullerton said, “As a specialty, what we do is inherently high-risk and…requires great skill and leadership. ABTS board certification is a tangible demonstration that one has accomplished what is required to be a thoracic surgeon.”

Dr. Fullerton also held prominent leadership positions at the American College of Surgeons, Thoracic Surgery Directors Association, Thoracic Surgery Foundation, and Western Thoracic Surgical Association.

Throughout his career, Dr. Fullerton received numerous honors and awards, including recognitions as America’s Top Doctor and Best Doctors in America. He was a sought-after speaker at medical conferences. His passion for education was evident in his mentorship of young surgeons, many of whom went on to achieve great success in their own careers.

Dr. Fullerton's legacy extends far beyond his technical expertise. He was known for his integrity, his unwavering commitment to his patients, and his generosity in sharing knowledge. He mentored hundreds of medical students, residents, and colleagues in both academia and community-based practice.

His genial and welcoming nature defined him. He was truly the quintessential gentleman – respectful and always lending an ear and his keen mind to listen to a variety of opinions and thoughts from anyone. Dr. Fullerton's contributions to the profession have left an enduring mark on the specialty, and his influence will be felt for years to come.

He is survived by his wife, Christine, sons Patrick and Daniel, and a host of colleagues, friends, and former trainees who will remember him as a mentor, leader, and friend.

Image

A groundbreaking surgical achievement has been made by the team at West Virginia University (WVU) Heart and Vascular Institute, led by Dr. Vinay Badhwar, the executive chair of the WVU Heart and Vascular Institute and the second vice president of the Society of Thoracic Surgeons. On October 31, 2024, the team performed the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) through a single small incision.

Image

The pioneering procedure was performed on 73-year-old Poppy McGee, a patient with a complex medical history, including a stroke, brain surgery, and significant weight loss. Referred to Dr. Badhwar for treatment of both aortic valve disease and coronary artery disease, McGee initially faced the prospect of traditional open-heart surgery. However, when she and her family learned of its risks—over a 10% chance of mortality and nearly 50% likelihood of complications—they inquired about alternative options.

Dr. Badhwar explained his team had developed a novel robotic approach that had yet to be tested on a patient. After a thorough discussion of the risks and benefits, McGee and her family agreed to proceed with the innovative robotic surgery.

The procedure involved both AVR and CABG, performed entirely robotically through a single incision on the far right of McGee’s chest. The success of the surgery has sparked optimism about the potential for broader adoption of robotic heart surgery for patients with complex conditions.

“While we are still in the early days of this latest innovation, the ability to perform valve surgery and coronary artery bypass surgery fully robotically through a single incision has the potential to open up a new era of robotic heart surgery,” Dr. Badhwar noted in a prepared statement. “We must always keep quality outcomes at the forefront of all innovation. However, if surgeons adopt and gain experience with techniques such as this one, they will tackle this last frontier that previously limited a robotic approach. One day in the near future, this may serve as a platform to perform nearly all types of heart surgery.”

This revolutionary procedure potentially paves the way for less invasive operations. Dr. Lawrence Wei, a professor at the WVU Department of Cardiovascular and Thoracic Surgery, remarked on the impact of this advancement: "Patients who have both valve disease and coronary artery disease have traditionally been treated by open-heart surgery performed through the breastbone. This new robotic technique could redefine how we approach these cases."

Dr. Goya Raikar, an assistant professor at WVU and a member of Badhwar’s robotics team, also underscored the procedure's significance: "Until now, the main exclusion for us to perform a robotic approach has been the coexistence of valve and coronary artery disease. Building on our experience with robotic aortic valve surgery, this new approach may help us extend robotic surgery options to many more patients."

The patient’s daughter, Mollie Wilcosky, expressed gratitude for the groundbreaking care provided by the WVU team. “We are so thankful for Dr. Badhwar and the team at the WVU Heart and Vascular Institute for developing this robotic procedure to help my mother recover so well,” Wilcosky said. “She is getting stronger every day.”

The full details of the procedure will be in The Annals of Thoracic Surgery, highlighting how innovative approaches like this continue to redefine the future of cardiothoracic surgery.

References:
•    Cardiovascular Business article on the WVU Heart and Vascular Institute's groundbreaking surgery.
•    WV News article detailing the multidisciplinary team and procedural innovations at WVU Medicine’s WVU Heart and Vascular Institute.
 

On October 25-26, 2024, more than 230 members of perioperative and critical care teams from around the world gathered in Philadelphia for the 2024 Perioperative & Critical Care Conference. The conference focused on the latest techniques and management strategies in cardiovascular and thoracic critical care, as well as enhanced recovery after surgery. Participants gained valuable insights and practical strategies aimed at optimizing patient care and improving outcomes. 

The two-day event covered a wide range of topics, including fundamentals of waveforms and monitoring, goal-directed hemodynamic therapy and AKI prevention, ECMO fundamentals, improving communication in the cardiothoracic intensive care unit, and vasoplegia management. 

Here's what a few attendees said about the Perioperative & Critical Care Conference:

•  "In the ECMO session, we not only saw the latest in technology and innovation, but also learned techniques that will help us treat our patients and get them out of the hospital in better condition,” Dr. Jeremiah Hayanga, West Virginia University Health System
• "The conference was well-paced and engaging. The speakers were captivating, and the discussions were thought-provoking. The two days flew by!"
• "The STS team did a fantastic job with the logistics of this large-scale conference. The recordings and slides will be a great way to review the material and share it with colleagues.”
• "The conference was informative and highlighted areas where we can improve our practices. I appreciate the multidisciplinary focus, which is essential for optimal patient care."
•  "As an APP, I truly enjoyed the conference and felt that the presentation and topics aligned well with my role. I look forward to attending again next year."

Check out our event photo gallery.